| Execution period | 5 years |
|---|
BSE filing, NSE: TRACXN. Summary written from the filing by ALFA Finder's alert engine.
Tracxn Technologies Ltd: key numbers
- Share price
- ₹29.44
- Market cap
- ₹314.9 Cr
- Revenue (annual)
- ₹83.97 Cr
- Net profit (annual)
- ₹-7.89 Cr
- P/E (TTM)
- -26.2×Sector 22.9×
- Promoter holding
- 34.61%-0.02% QoQ
- FII holding
- 0.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tracxn Technologies Ltd
All →Tracxn Technologies Other Announcement
Tracxn Technologies Ltd submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
Tracxn Technologies Product Launch
Tracxn Technologies has launched its AI Suite, an integrated tool designed to streamline business research by enabling natural-language queries directly within existing AI workflows.
Tracxn Technologies Employee Stock Options
Tracxn Technologies Limited allotted 18,620 equity shares to employees upon the exercise of options granted under its Employee Stock Option Plan 2016.
Tracxn Technologies Employee Stock Options
Tracxn Technologies allotted 18,620 equity shares under its Employee Stock Option Plan 2016. The exercise raised ₹0.0019 Crore for the company.
- Value
- ₹0.00 Cr
Tracxn Technologies Employee Stock Options
Tracxn Technologies allotted 30,048 equity shares to employees under ESOP 2016 at Re. 1 per share. Paid-up capital rose to 10,69,55,079 shares.
Tracxn Technologies Employee Stock Options
Tracxn Technologies Limited announced the grant of 135,404 stock options to eligible employees under its ESOP 2016 plan.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.